PlainRecalls
CriticalClass ITerminated

FDA Devices recall · Reported July 7, 2021

LeadCare II Blood Lead Test Kit Catalog Number 70-6762

Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead le…

Recall #
Z-1952-2021
Affected scope
387,281 kits (48 tests/kit=1,757,040 tests)
Initiated
May 7, 2021
Compiled from official public sources by the editorial team.
Verify with FDA Devices →
View my saved recalls

Magellan Diagnostics, Inc. recalled LeadCare II Blood Lead Test Kit Catalog Number 70-6762 - a critical-severity action.

LeadCare II Blood Lead Test Kit Catalog Number 70-6762 was recalled by Magellan Diagnostics, Inc. in July 7, 2021. Reason: Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated …. Check the official notice for the remedy. Verify recall #Z-1952-2021 with the FDA Devices before acting.

The recall

Magellan Diagnostics, Inc. issued this critical-severity FDA Devices recall-Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated ….

Critical
severity level
Class I
classification
July 7, 2021
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-1952-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Devices action (record #Z-1952-2021) was formally reported on July 7, 2021, with the manufacturer initiating the action on May 7, 2021. It is classified under Critical severity (Class I), with a current status of Terminated. Magellan Diagnostics, Inc. is listed as the recalling firm, operating out of North Billerica, MA. Federal records list the affected scope as 387,281 kits (48 tests/kit=1,757,040 tests).

The documented reason for this recall is: Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient samples. Distribution data in the federal record shows the product reached: Worldwide distribution. US nationwide including Puerto Rico; Canada, Vietnam, India, Italy, Peru, New Zealand, Australia, Hong Kong, and Philippines.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 40,409 medical devices recalls on record

-1,00001,0002,0003,0004,0005,000 20052008201120142017202020232026 1,243

Where this recall sits in the database

Severity2366872097High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Critical

Affected scope

387,281 kits (48 tests/kit=1,757,040 tests)

Related Recalls

6

6 from same agency

Product description

LeadCare II Blood Lead Test Kit Catalog Number 70-6762

Reason for recall

Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient samples.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Critical (Class I)
Status Terminated
Recall number Z-1952-2021
Date reported July 7, 2021
Date initiated May 7, 2021
Recalling firm Magellan Diagnostics, Inc.
Firm location North Billerica, MA
Affected scope 387,281 kits (48 tests/kit=1,757,040 tests)
Distribution Worldwide distribution. US nationwide including Puerto Rico; Canada, Vietnam, India, Italy, Peru, New Zealand, Australia, Hong Kong, and Philippines.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-1952-2021) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
LeadCare II Blood Lead Test Kit Catalog Number 70-6762. Recalled by Magellan Diagnostics, Inc.. Units affected: 387,281 kits (48 tests/kit=1,757,040 tests).
Why was this product recalled?
Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient samples.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 7, 2021. Severity: Critical. Recall number: Z-1952-2021.
Where was the recalled product distributed?
Distribution: Worldwide distribution. US nationwide including Puerto Rico; Canada, Vietnam, India, Italy, Peru, New Zealand, Australia, Hong Kong, and Philippines..
How do I check if my product is affected by a recall?
Check the product description and recall number (Z-1952-2021) against your product. Visit the official FDA Devices website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with GE HealthCare TRADE IN CARESCAPE TELEMETRY SERVER ARK-2250L… →

Browse all Medical Devices recalls →

Data Sources

Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Devices, reported July 7, 2021.

  • Source: FDA - Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
  • Source: CPSC - Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
  • Source: NHTSA - National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)

Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.